ArticleCEN case reports2025

Good response with nivolumab and cabozantinib combination therapy in patients with metastatic collecting duct carcinoma with high expression of PD-L1, c-MET, and AXL.

Tatsuya Umemoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.